As COP 29 unfolds, there is growing hope that cultivated meat may finally gain the essential financial and regulatory support needed to achieve scalability and commercial success. Che Connon, managing

Kerato’s innovative “biosynthetic cornea” provides a promising alternative to traditional donor corneal transplants. Designed for one-time use, this injectable device is administered single-handedly. It forms a self-sealing gel in the

BSF Enterprise, along with its subsidiaries, has recently achieved ISO 9001 certification, a globally recognised standard for quality management systems. This accomplishment signifies a strong commitment to quality across all

CytoBoost is a new, premium approach to cell culture, offering laboratories a way to enhance the health and performance of their cells. With this innovative product, you can think of

BSF Enterprise plc, a UK-based biotechnology investment company, has been at the forefront of sustainable innovation, especially through its subsidiary, Lab-Grown Leather. Managing Director Dr. Che Connon recently discussed how

Europe’s approach to the agri-tech revolution is increasingly viewed as outdated, with its regulations often criticised as overly protectionist and wary of technological advancements. The continent’s approach to cell-grown meat

The aging global population is driving a rise in vision impairment, which in turn affects physical, cognitive, and mental health. Among the most commonly transplanted human tissues worldwide are corneas,